I-Mab (IMAB)
NASDAQ: IMAB · Real-Time Price · USD
1.090
+0.020 (1.87%)
Nov 4, 2024, 4:00 PM EST - Market closed
I-Mab Employees
I-Mab had 220 employees as of December 31, 2023. The number of employees decreased by 158 or -41.80% compared to the previous year.
Employees
220
Change
-158
Growth
-41.80%
Revenue / Employee
$15,873
Profits / Employee
-$508,101
Market Cap
88.76M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 220 | -158 | -41.80% |
Dec 31, 2021 | 378 | 150 | 65.79% |
Dec 31, 2020 | 228 | 43 | 23.24% |
Dec 31, 2019 | 185 | 51 | 38.06% |
Dec 31, 2018 | 134 | - | - |
Related Stocks
Company Name | Employees |
---|---|
So-Young International | 1,357 |
Agenus | 389 |
PetMed Express | 287 |
WORK Medical Technology Group LTD | 216 |
X4 Pharmaceuticals | 93 |
Chimerix | 72 |
Armata Pharmaceuticals | 66 |
PMV Pharmaceuticals | 63 |
IMAB News
- 4 days ago - I-Mab to Release Q3 2024 Financial Results on November 14, 2024 - PRNewsWire
- 5 days ago - I-Mab to Present Givastomig Phase 1 Optimal Dose Estimation Data at SITC 2024 - PRNewsWire
- 7 days ago - I-Mab to Participate at the Truist Securities BioPharma Symposium - PRNewsWire
- 7 weeks ago - I-Mab Presents Updated Phase 1 Givastomig Data at ESMO 2024 - PRNewsWire
- 7 weeks ago - I-Mab Presents Positive Uliledlimab Pharmacokinetics Data at 2024 World Conference on Lung Cancer - PRNewsWire
- 2 months ago - I-MAB (IMAB) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - I-Mab Reports 1H 2024 Financial Results, Pipeline Progress, and Business Updates - PRNewsWire
- 2 months ago - I-Mab to Participate at the H.C. Wainwright 26th Annual Global Investment Conference - PRNewsWire